Bedel Financial Consulting »

Ocuphire Pharma shares owned by Bedel Financial Consulting

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Bedel Financial Consulting from 13F filings

Historical chart of Bedel Financial Consulting investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Bedel Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Bedel Financial Consulting

Quarter filed Position value Share count Share price at filing
2023-09-30 $50k 15k 3.35

More positions owned by Bedel Financial Consulting

Eli Lilly & Co. (LLY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Apple (AAPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Grwth Etf (EFG)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Innovator Etfs Tr Us Eqt Pwr Buf (PAPR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Global X Fds Rate Preferred (PFFV)
JPMorgan Chase & Co. (JPM)
Ishares Tr MRGSTR MD CP GRW (IMCG)

View all positions for Bedel Financial Consulting

Top funds holding Ocuphire Pharma

Perceptive Advisors
BIOS Capital Management
Nantahala Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Voss Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Creative Planning
Citadel Advisors
Two Sigma Investments

View all funds holding Ocuphire Pharma